pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4260 |
Genomic Coordinates | chr1: 209623444 - 209623510 |
Description | Homo sapiens miR-4260 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4260 | ||||||||||||
Sequence | 11| CUUGGGGCAUGGAGUCCCA |29 | ||||||||||||
Evidence | Experimental | ||||||||||||
Experiments | SOLiD | DRVs in miRNA |
|
||||||||||
SNPs in miRNA |
|
||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |
---|---|
Gene Symbol | UBBP4 |
Experimental Support 1 for Functional miRNA-Target Interaction | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
miRNA:Target | ---- | |||||||||
Validation Method |
|
|||||||||
Conditions | HEK293 | |||||||||
Location of target site | 3'UTR | |||||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | |||||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545214. RNA binding protein: AGO3. Condition:Control
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
|||||||||
miRNA-target interactions (Provided by authors) |
|
|||||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 23666.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714647. RNA binding protein: AGO2. Condition:mildMNase
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 23666.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065667. RNA binding protein: AGO1. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
CLIP-seq Support 1 for dataset GSM545214 | |
---|---|
Method / RBP | PAR-CLIP / AGO3 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000583708.1 | 3UTR | UGAUGGCAUUACUCUGCACUAUAGCCAUUUGCCCCAACU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM714647 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / mildMNase, repB |
Location of target site | ENST00000583708.1 | 3UTR | UGAUGGCAUUACUCUGCACUAUAGCCAUUUGCCCCAACU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM1065667 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_6 |
Location of target site | ENST00000583708.1 | 3UTR | UGAUGGCAUUACUCUGCACUAUAGCCAUUUGCCCCAACUUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
66 hsa-miR-4260 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT074404 | TNRC6A | trinucleotide repeat containing 6A | 2 | 2 | ||||||||
MIRT289774 | PER1 | period circadian clock 1 | 2 | 2 | ||||||||
MIRT442576 | HOXD9 | homeobox D9 | 2 | 2 | ||||||||
MIRT443878 | CNKSR3 | CNKSR family member 3 | 2 | 2 | ||||||||
MIRT449080 | XPO6 | exportin 6 | 2 | 2 | ||||||||
MIRT450294 | DRAXIN | dorsal inhibitory axon guidance protein | 2 | 2 | ||||||||
MIRT461785 | FXR2 | FMR1 autosomal homolog 2 | 2 | 2 | ||||||||
MIRT463931 | WNT10B | Wnt family member 10B | 2 | 2 | ||||||||
MIRT464860 | UBB | ubiquitin B | 2 | 8 | ||||||||
MIRT467619 | SLC7A5 | solute carrier family 7 member 5 | 2 | 2 | ||||||||
MIRT469649 | RAC1 | Rac family small GTPase 1 | 2 | 2 | ||||||||
MIRT473421 | MDM4 | MDM4, p53 regulator | 2 | 2 | ||||||||
MIRT473646 | MARCKSL1 | MARCKS like 1 | 2 | 2 | ||||||||
MIRT474213 | LCOR | ligand dependent nuclear receptor corepressor | 2 | 2 | ||||||||
MIRT474335 | KMT2D | lysine methyltransferase 2D | 2 | 2 | ||||||||
MIRT474871 | KDELR1 | KDEL endoplasmic reticulum protein retention receptor 1 | 2 | 2 | ||||||||
MIRT477440 | ELOVL5 | ELOVL fatty acid elongase 5 | 2 | 2 | ||||||||
MIRT478432 | DAZAP2 | DAZ associated protein 2 | 2 | 2 | ||||||||
MIRT479851 | CCDC6 | coiled-coil domain containing 6 | 2 | 2 | ||||||||
MIRT482507 | ACTB | actin beta | 2 | 2 | ||||||||
MIRT485473 | IGF1R | insulin like growth factor 1 receptor | 2 | 8 | ||||||||
MIRT485670 | CCDC64 | BICD family like cargo adaptor 1 | 2 | 4 | ||||||||
MIRT485902 | PGPEP1 | pyroglutamyl-peptidase I | 2 | 4 | ||||||||
MIRT488143 | PRRC2B | proline rich coiled-coil 2B | 2 | 4 | ||||||||
MIRT489455 | MSC | musculin | 2 | 2 | ||||||||
MIRT509568 | HIST2H2AB | histone cluster 2 H2A family member b | 2 | 4 | ||||||||
MIRT513093 | DYNAP | dynactin associated protein | 2 | 2 | ||||||||
MIRT513256 | CALM3 | calmodulin 3 | 2 | 2 | ||||||||
MIRT514356 | UBBP4 | ubiquitin B pseudogene 4 | 2 | 6 | ||||||||
MIRT522019 | PAQR3 | progestin and adipoQ receptor family member 3 | 2 | 4 | ||||||||
MIRT523164 | HIST3H3 | histone cluster 3 H3 | 2 | 2 | ||||||||
MIRT523297 | HIST1H1B | histone cluster 1 H1 family member b | 2 | 2 | ||||||||
MIRT524782 | BAG5 | BCL2 associated athanogene 5 | 2 | 2 | ||||||||
MIRT530921 | SCIN | scinderin | 2 | 2 | ||||||||
MIRT533302 | USP44 | ubiquitin specific peptidase 44 | 2 | 2 | ||||||||
MIRT552782 | YIPF4 | Yip1 domain family member 4 | 2 | 4 | ||||||||
MIRT553981 | SRPR | SRP receptor alpha subunit | 2 | 2 | ||||||||
MIRT563126 | ZNF215 | zinc finger protein 215 | 2 | 2 | ||||||||
MIRT569025 | IL21R | interleukin 21 receptor | 2 | 2 | ||||||||
MIRT573413 | RPL18A | ribosomal protein L18a | 2 | 2 | ||||||||
MIRT574877 | Dnajc6 | DnaJ heat shock protein family (Hsp40) member C6 | 2 | 3 | ||||||||
MIRT607538 | GLI2 | GLI family zinc finger 2 | 2 | 2 | ||||||||
MIRT607682 | MAPK10 | mitogen-activated protein kinase 10 | 2 | 3 | ||||||||
MIRT623791 | GK5 | glycerol kinase 5 (putative) | 2 | 2 | ||||||||
MIRT628834 | FAM151B | family with sequence similarity 151 member B | 2 | 2 | ||||||||
MIRT635547 | LEPREL1 | prolyl 3-hydroxylase 2 | 2 | 2 | ||||||||
MIRT635698 | NMNAT2 | nicotinamide nucleotide adenylyltransferase 2 | 2 | 2 | ||||||||
MIRT635906 | ARPC1B | actin related protein 2/3 complex subunit 1B | 2 | 2 | ||||||||
MIRT649985 | MSI1 | musashi RNA binding protein 1 | 2 | 2 | ||||||||
MIRT654900 | POMGNT1 | protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-) | 2 | 2 | ||||||||
MIRT655116 | PHF7 | PHD finger protein 7 | 2 | 2 | ||||||||
MIRT658958 | DNAJC6 | DnaJ heat shock protein family (Hsp40) member C6 | 2 | 3 | ||||||||
MIRT659665 | CDC42EP4 | CDC42 effector protein 4 | 2 | 2 | ||||||||
MIRT668946 | CNBP | CCHC-type zinc finger nucleic acid binding protein | 2 | 2 | ||||||||
MIRT691164 | APOL6 | apolipoprotein L6 | 2 | 2 | ||||||||
MIRT692696 | MEAF6 | MYST/Esa1 associated factor 6 | 2 | 2 | ||||||||
MIRT693245 | HBS1L | HBS1 like translational GTPase | 2 | 2 | ||||||||
MIRT695203 | SCAMP3 | secretory carrier membrane protein 3 | 2 | 2 | ||||||||
MIRT701957 | MINK1 | misshapen like kinase 1 | 2 | 2 | ||||||||
MIRT706802 | APOL4 | apolipoprotein L4 | 2 | 2 | ||||||||
MIRT716899 | CACNB2 | calcium voltage-gated channel auxiliary subunit beta 2 | 2 | 2 | ||||||||
MIRT717632 | HLX | H2.0 like homeobox | 2 | 2 | ||||||||
MIRT719052 | ZNF281 | zinc finger protein 281 | 2 | 2 | ||||||||
MIRT722973 | GDE1 | glycerophosphodiester phosphodiesterase 1 | 2 | 2 | ||||||||
MIRT723643 | RPTN | repetin | 2 | 2 | ||||||||
MIRT734708 | NR3C2 | nuclear receptor subfamily 3 group C member 2 | 4 | 0 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|